Hydroxymethylglutaryl-CoA Reductase Inhibitors Concept

subject area of

• 2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult  Academic Article
• 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults  Academic Article
• d-Dimer Testing to Select Patients With a First Unprovoked Venous Thromboembolism Who Can Stop Anticoagulant Therapy  Academic Article
• A Canadian Critical Care Trials Group project in collaboration with the international forum for acute care trialists - Collaborative H1N1 Adjuvant Treatment pilot trial (CHAT): study protocol and design of a randomized controlled trial  Academic Article
• A Model for Assessing the Cost-Effectiveness of Atorvastatin and Simvastatin in Achieving Canadian Low-Density Lipoprotein Cholesterol Targets  Academic Article
• A Neuromuscular Approach to Statin-Related Myotoxicity  Academic Article
• A Randomized Crossover Trial of Combination Pharmacologic Therapy in Children with Familial Hyperlipidemia  Academic Article
• A comparison of pravastatin and gemfibrozil in the treatment of dyslipoproteinemia in patients with non-insulin-dependent diabetes mellitus  Academic Article
• A new method for measurement of total plasma PCSK9: clinical applications  Academic Article
• A randomized, placebo-controlled, double-blind trial to evaluate efficacy and safety of Shen-Yuan-Dan capsules, a traditional Chinese medicine, for treatment of peri-procedure myocardial injury following percutaneous coronary intervention  Academic Article
• A review of the effects of statins in systemic sclerosis  Academic Article
• A survey of physicians show a one-third reduction in harmful outcomes to be a clinically important difference for statin therapy  Academic Article
• A treatment decision aid may increase patient trust in the diabetes specialist. TheStatin Choicerandomized trial  Academic Article
• Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: Design and Methods  Academic Article
• Addition of Ezetimibe to statins for patients at high cardiovascular risk: Systematic review of patient‐important outcomes  Academic Article
• Adjunctive Therapy in Community-Acquired Pneumonia  Academic Article
• Adverse events associated with individual statin treatments for cardiovascular disease: an indirect comparison meta-analysis  Academic Article
• Age and sex differences, and changing trends, in the use of evidence-based therapies in acute coronary syndromes: perspectives from a multinational registry  Academic Article
• An assessment by the Statin Muscle Safety Task Force: 2014 update  Academic Article
• Anabolic Agents: A New Chapter in the Management of Osteoporosis  Academic Article
• Antihypertensives and Statin Therapy for Primary Stroke Prevention: A Secondary Analysis of the HOPE-3 Trial  Academic Article
• Are Patients with Inflammatory Bowel Disease at Increased Risk of Coronary Artery Disease?  Academic Article
• Are the ACC/AHA Guidelines on the Treatment of Blood Cholesterol a Game Changer? A Perspective From the Canadian Cardiovascular Society Dyslipidemia Panel  Academic Article
• Assessment of the longer-term effects of a dietary portfolio of cholesterol-lowering foods in hypercholesterolemia  Academic Article
• Association Between Preoperative Statin Use and Acute Kidney Injury Biomarkers in Cardiac Surgical Procedures  Academic Article
• Association between pre-operative statin use and major cardiovascular complications among patients undergoing non-cardiac surgery: the VISION study  Academic Article
• Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes  Academic Article
• Association of Statin Therapy with Outcomes of Acute Coronary Syndromes: The GRACE Study  Academic Article
• Association of Statins and Statin Discontinuation With Poor Outcome and Survival After Intracerebral Hemorrhage  Academic Article
• Association of common variants in the human eyes shut ortholog (EYS) with statin-induced myopathy: Evidence for additional functions of EYS  Academic Article
• Association of statin therapy and the risk of atrial fibrillation in patients with a permanent pacemaker  Academic Article
• Atorvastatin Delays Murine Platelet Activation In Vivo Even in the Absence of Endothelial NO Synthase  Academic Article
• Atorvastatin Restores Endothelial Function in Normocholesterolemic Smokers Independent of Changes in Low-Density Lipoprotein  Academic Article
• Atorvastatin for high-risk statin-naïve patients undergoing noncardiac surgery: The Lowering the Risk of Operative Complications Using Atorvastatin Loading Dose (LOAD) randomized trial  Academic Article
• Author’s response  Academic Article
• Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data  Academic Article
• Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data.  Academic Article
• Back to Back: All people over 75 years with a five-year CVD risk of ≥ 15% should be treated with statins unless specifically contraindicated: No  Academic Article
• Beta-blockers and cardiovascular outcomes in dialysis patients: a cohort study in Ontario, Canada  Academic Article
• Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient  Academic Article
• Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease studies  Academic Article
• Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease  Academic Article
• Building Your Peripheral Artery Disease Toolkit: Medical Management of Peripheral Artery Disease in 2022  Academic Article
• C-reactive protein is a mediator of cardiovascular disease  Academic Article
• Canadian Cardiovascular Society Guidelines for the Diagnosis and Management of Stable Ischemic Heart Disease  Academic Article
• Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia: Update 2018  Academic Article
• Canadian stroke best practice consensus statement: Secondary stroke prevention during pregnancy  Academic Article
• CardioDiabetes: Core Competencies for Cardiovascular Clinicians in a Rapidly Evolving Era of Type 2 Diabetes Management  Academic Article
• Cardiovascular Risk Factors and In-hospital Mortality in Acute Coronary Syndromes: Insights From the Canadian Global Registry of Acute Coronary Events  Academic Article
• Case selection for statins was similar in two Canadian provinces: BC and Ontario  Academic Article
• Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease  Academic Article
• Clinical Perspectives of Statin-Induced Rhabdomyolysis  Academic Article
• Clinical Usefulness of Tissue Doppler Imaging in Patients with Mild to Moderate Aortic Stenosis: A Substudy of the Aortic Stenosis Progression Observation Measuring Effects of Rosuvastatin Study  Academic Article
• Clinical decisions. Management of stable coronary disease.  Academic Article
• Clinical features related to statin‐associated muscle symptoms  Academic Article
• Clinician's use of theStatin Choicedecision aid in patients with diabetes: a videographic study nested in a randomized trial  Academic Article
• Cochrane corner: early statin therapy in acute coronary syndromes—what is the clinical benefit?  Academic Article
• Coenzyme A Reductase Inhibitors and Stroke  Academic Article
• Cognitive Function and Brain Structure in Persons With Type 2 Diabetes Mellitus After Intensive Lowering of Blood Pressure and Lipid Levels  Academic Article
• Colchicine for Secondary Prevention of Cardiovascular Disease  Academic Article
• Combination Therapy to Prevent Cardiovascular Disease  Academic Article
• Comparison of Risk Factor Reduction and Tolerability of a Full-Dose Polypill (With Potassium) Versus Low-Dose Polypill (Polycap) in Individuals at High Risk of Cardiovascular Diseases  Academic Article
• Comparison of Rosuvastatin Versus Atorvastatin in South-Asian Patients at Risk of Coronary Heart Disease (from the IRIS Trial)  Academic Article
• Comparison of Utilization of Statin Therapy at Hospital Discharge and Six-Month Outcomes in Patients With an Acute Coronary Syndrome and Serum Low-Density Lipoprotein ≥100 mg/dl Versus <100 mg/dl  Academic Article
• Comparison of a dietary portfolio diet of cholesterol-lowering foods and a statin on LDL particle size phenotype in hypercholesterolaemic participants  Academic Article
• Computational pharmacogenomic screen identifies drugs that potentiate the anti-breast cancer activity of statins  Academic Article
• Concurrent use of statins and neoadjuvant chemoradiotherapy for rectal cancer: a systematic review and meta-analysis  Academic Article
• Cost-Effectiveness of Polygenic Risk Scores to Guide Statin Therapy for Cardiovascular Disease Prevention  Academic Article
• Delayed educational reminders for long-term medication adherence in ST-elevation myocardial infarction (DERLA-STEMI): Protocol for a pragmatic, cluster-randomized controlled trial  Academic Article
• Detection of atherosclerotic cardiovascular disease influences the perceived need for aggressive lipid management  Academic Article
• Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update (2016)  Academic Article
• Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Working Group Consensus Update  Academic Article
• Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Proceedings of a Canadian Working Group Consensus Conference  Academic Article
• Direct comparison of a dietary portfolio of cholesterol-lowering foods with a statin in hypercholesterolemic participants1–3  Academic Article
• Direct comparison of dietary portfolio vs statin on C-reactive protein  Academic Article
• Discordance Between Physicians' Estimation of Patient Cardiovascular Risk and Use of Evidence-Based Medical Therapy  Academic Article
• Does Googling lead to statin intolerance?  Academic Article
• Does Statin Therapy Decrease the Risk for Bleeding in Patients Who Are Receiving Warfarin?  Academic Article
• Does the Number of Pharmacies a Patient Frequents Affect Adherence to Statins?  Academic Article
• Does the magnitude of lipid lowering with statin therapy indicate higher intracranial bleeding risk?  Academic Article
• Drug Therapies in the Secondary Prevention of Cardiovascular Diseases:Successes, Shortcomings and Future Directions  Academic Article
• Dyslipidemia in systemic lupus erythematosus: just another comorbidity?  Academic Article
• Early Withdrawal of Statin Therapy in Patients With Non–ST-Segment Elevation Myocardial Infarction<subtitle>National Registry of Myocardial Infarction</subtitle>  Academic Article
• Effect of Different Antilipidemic Agents and Diets on Mortality  Academic Article
• Effect of Evolocumab or Ezetimibe Added to Moderate- or High-Intensity Statin Therapy on LDL-C Lowering in Patients With Hypercholesterolemia  Academic Article
• Effect of HMGcoA Reductase Inhibitors on Stroke  Academic Article
• Effect of Lipid Lowering With Rosuvastatin on Progression of Aortic Stenosis  Academic Article
• Effect of Statin Use Within the First 24 Hours of Admission for Acute Myocardial Infarction on Early Morbidity and Mortality††A complete list of participating hospitals is available from ClinTrials Research, 1100 Weston Parkway, Cary, North Carolina 27513.  Academic Article
• Effect of rosuvastatin on C-reactive protein and progression of aortic stenosis  Academic Article
• Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials  Academic Article
• Effect of statins on disease-related outcomes in patients with idiopathic pulmonary fibrosis  Academic Article
• Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus  Academic Article
• Effects of Early Treatment With Statins on Short-term Clinical Outcomes in Acute Coronary Syndromes  Academic Article
• Effects of Ezetimibe Add-on to Statin Therapy on Adipokine Production in Patients With Metabolic Syndrome and Stable Vascular Disease  Academic Article
• Effects of a Dietary Portfolio of Cholesterol-Lowering Foods vs Lovastatin on Serum Lipids and C-Reactive Protein  Academic Article
• Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial  Academic Article
• Effects of routine early treatment with PCSK9 inhibitors in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a randomised, double-blind, sham-controlled trial&nbsp;  Academic Article
• Effects of statins on stroke prevention in patients with and without coronary heart disease: A meta-analysis of randomized controlled trials  Academic Article
• Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance  Academic Article
• Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials  Academic Article
• Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials  Academic Article
• Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials  Academic Article
• Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170 255 patients from 76 randomized trials  Academic Article
• Elevations in Creatine Kinase are Not Related to the Choice or Dose of Statins in Patients Taking Colchicine 0.5 mg Daily: Insights from the LoDoCo2 Trial  Academic Article
• Evaluating the Impact of Statin Use on Influenza Vaccine Effectiveness and Influenza Infection in Older Adults  Academic Article
• Evaluating the effectiveness of rosuvastatin in preventing the progression of diastolic dysfunction in aortic stenosis: A substudy of the aortic stenosis progression observation measuring effects of rosuvastatin (ASTRONOMER) study  Academic Article
• Evolocumab in HIV-Infected Patients With Dyslipidemia  Academic Article
• Exploring patient demographic and clinical characteristics associated with lipid-lowering pharmacotherapy use in primary care  Academic Article
• Ezetimibe in high-risk, previously treated statin patients: a systematic review and network meta-analysis of lipid efficacy  Academic Article
• Fluvastatin Causes NLRP3 Inflammasome-Mediated Adipose Insulin Resistance  Academic Article
• Genetic risk factors associated with lipid-lowering drug-induced myopathies  Academic Article
• HOPE­‑3, BP treatment, milestones in CV prevention. Dr. Salim Yusuf in an interview with Dr. Akbar Panju and Dr. Roman Jaeschke  Academic Article
• Helping Patients With Type 2 Diabetes Mellitus Make Treatment Decisions  Conference Paper
• Higher potency statins and the risk of new diabetes: multicentre, observational study of administrative databases  Academic Article
• How should the impact of different presentations of treatment effects on patient choice be evaluated? A pilot randomized trial  Academic Article
• Hyperglycaemic disorders associated with PCSK9 inhibitors: a real-world, pharmacovigilance study  Academic Article
• Identifying and Treating Young Patients at Risk for Cardiovascular Events  Academic Article
• Immunomodulatory agents for the treatment of cachexia  Academic Article
• Impact of Metabolic Syndrome on Progression of Aortic Stenosis  Academic Article
• Impact of blood pressure lowering, cholesterol lowering and their combination in Asians and non-Asians in those without cardiovascular disease: an analysis of the HOPE 3 study  Academic Article
• Impact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-ST-segment elevation acute coronary syndromes: perspectives from a large multinational registry  Academic Article
• Impact of diabetes, angiotensin‐converting enzyme inhibitor or angiotensin II receptor blocker use, and statin use on presentation and outcomes in patients with giant cell arteritis  Conference Paper
• Impact of routine in-hospital assessment of low-density lipoprotein levels and standardized orders on statin therapy in patients undergoing percutaneous coronary interventions.  Academic Article
• Incorporating multiple interventions in meta-analysis: an evaluation of the mixed treatment comparison with the adjusted indirect comparison  Academic Article
• Indications for Coronary Artery Bypass Surgery and Percutaneous Coronary Intervention in Chronic Stable Angina  Academic Article
• Inhibition of thrombin generation by simvastatin and lack of additive effects of aspirin in patients with marked hypercholesterolemia  Academic Article
• Insulin Resistance and LVH Progression in Patients With Calcific Aortic Stenosis  Academic Article
• Intensity of and Adherence to Lipid‐Lowering Therapy as Predictors of Major Adverse Cardiovascular Outcomes in Patients With Coronary Heart Disease  Academic Article
• Intensive statin therapy compared with moderate dosing for prevention of cardiovascular events: a meta-analysis of >40 000 patients  Academic Article
• International Geographic Variation in Event Rates in Trials of Heart Failure With Preserved and Reduced Ejection Fraction  Academic Article
• International Prevalence, Recognition, and Treatment of Cardiovascular Risk Factors in Outpatients With Atherothrombosis  Academic Article
• Interpretation of the evidence for the efficacy and safety of statin therapy  Academic Article
• Interventions supporting long term adherence and decreasing cardiovascular events after myocardial infarction (ISLAND): pragmatic randomised controlled trial  Academic Article
• Is aggressive lipid‐lowering therapy preferable to angioplasty in stable coronary artery disease?  Academic Article
• Lack of Effect of Lowering LDL Cholesterol on Cancer: Meta-Analysis of Individual Data from 175,000 People in 27 Randomised Trials of Statin Therapy  Academic Article
• Length of Initial Prescription at Hospital Discharge and Long-term Medication Adherence for Elderly Patients With Coronary Artery Disease: A Population-Level Study  Academic Article
• Limitations of statin monotherapy for the treatment of dyslipidemia: a projection based on the Canadian lipid study – observational  Academic Article
• Lipid Management in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2013 Clinical Practice Guideline  Academic Article
• Lipid lowering for primary prevention  Academic Article
• Lipid-lowering treatment intensity, persistence, adherence and goal attainment in patients with coronary heart disease  Academic Article
• Liver-specific ATP-citrate lyase inhibition by bempedoic acid decreases LDL-C and attenuates atherosclerosis  Academic Article
• Local statins used as an adjunct to nonsurgical periodontal treatment decrease residual pocket depth and increase clinical attachment level  Academic Article
• Long-term Effects of Statins, Blood Pressure-Lowering, and Both on Erectile Function in Persons at Intermediate Risk for Cardiovascular Disease: A Substudy of the Heart Outcomes Prevention Evaluation-3 (HOPE-3) Randomized Controlled Trial  Academic Article
• Long-term outcomes after acute myocardial infarction in countries with different socioeconomic environments: an international prospective cohort study  Academic Article
• Lovastatin Sensitizes Lung Cancer Cells to Ionizing Radiation: Modulation of Molecular Pathways of Radioresistance and Tumor Suppression  Academic Article
• Low Levels of High-Density Lipoprotein Cholesterol and Increased Risk of Cardiovascular Events in Stable Ischemic Heart Disease Patients  Academic Article
• Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Lowering With Atorvastatin in Patients of South Asian Compared With European Origin: Insights From the Achieve Cholesterol Targets Fast With Atorvastatin Stratified Titration (ACT  Academic Article
• Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease  Academic Article
• Management of acute coronary syndromes in developing countries: acute coronary events-a multinational survey of current management strategies.  Academic Article
• Medical Treatment of Peripheral Arterial Disease  Academic Article
• Metabolic Myopathies Discovered During Investigations of Statin Myopathy  Academic Article
• Missed opportunities for the secondary prevention of cardiovascular disease in Canada  Academic Article
• Modulation of arterial reactivity using amlodipine and atorvastatin measured by ultrasound examination (MARGAUX)  Academic Article
• Molecular clues into the pathogenesis of statin-mediated muscle toxicity  Academic Article
• Myocardial injury after noncardiac surgery  Academic Article
• Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy  Academic Article
• Nitrous Oxide and Serious Morbidity and Mortality in the POISE Trial  Academic Article
• Optimal Medical Therapy, Lifestyle Intervention, and Secondary Prevention Strategies for Cardiovascular Event Reduction in Ischemic Heart Disease  Academic Article
• Optimizing Cholesterol Treatment in Patients With Muscle Complaints  Academic Article
• Ovarian tumour growth is characterized by mevalonate pathway gene signature in an orthotopic, syngeneic model of epithelial ovarian cancer  Academic Article
• Overview of Therapeutic Approaches for Cholesterol Lowering and Attenuation of Thrombosis for Prevention of Atherothrombosis  Academic Article
• PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a clinical practice guideline with risk-stratified recommendations  Academic Article
• PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk reduction: a systematic review and network meta-analysis  Academic Article
• Part 9: Acute Coronary Syndromes  Academic Article
• Persistence and adherence to cholesterol lowering agents: Evidence from Régie de l'Assurance Maladie du Québec data  Academic Article
• Polypill for Cardiovascular Disease Prevention—Reply  Academic Article
• Polypill: the evidence and the promise  Academic Article
• Pooled RCTs: Lowering LDL-C levels using statins reduces major vascular events in all age groups  Academic Article
• Pre-Hospital Cardiac Arrest in Acute Coronary Syndromes: Insights from the Global Registry of Acute Coronary Events and the Canadian Registry of Acute Coronary Events  Academic Article
• Preoperative Statin Use and Postoperative Acute Kidney Injury  Academic Article
• Prevention of Cardiovascular Disease in Persons with Type 2 Diabetes Mellitus: Current Knowledge and Rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial  Academic Article
• Pre‐ and post‐stroke oral antithrombotics and mortality in patients with ischaemic stroke  Academic Article
• Primary Prevention With Statin Therapy in the Elderly  Academic Article
• Primary Prevention of Cardiovascular Mortality and Events With Statin Treatments  Academic Article
• Progressive muscle weakness: More there than meets the eye  Academic Article
• Rapid increase in statins newly dispensed to Ontario seniors between 1994 and 2000.  Academic Article
• Rationale, design, and baseline characteristics of a randomized trial to assess the effect of cholesterol lowering on the progression of aortic stenosis  Academic Article
• Reaching recommended lipid and blood pressure targets with amlodipine/atorvastatin combination in patients with coronary heart disease  Academic Article
• Reasons for resistance to aspirin in cardiovascular disease.  Academic Article
• Relative effects of LDL-C on ischemic stroke and coronary disease  Academic Article
• Repurposing Two Old Friends to Fight Cancer: Caffeine and Statins  Academic Article
• Results of a randomized controlled trial on statin use in dialysis patients had no influence on statin prescription  Academic Article
• Risk Factors, Use of Preventive Drugs, and Cardiovascular Events in Diabetes Mellitus: The PURE Türkiye Cohort  Academic Article
• Risk of adverse events among older adults following co-prescription of clarithromycin and statins not metabolized by cytochrome P450 3A4  Academic Article
• Role of genetics in the prediction of statin-associated muscle symptoms and optimization of statin use and adherence  Academic Article
• Role of statins in the prevention of post-thrombotic syndrome after a deep vein thrombosis event: a systematic review and meta-analysis  Academic Article
• Rosuvastatin Reduces Aortic Sinus and Coronary Artery Atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) Double Knockout Mice Independently of Plasma Cholesterol Lowering  Academic Article
• Rosuvastatin for the prevention of venous thromboembolism: a pooled analysis of the HOPE-3 and JUPITER randomized controlled trials  Academic Article
• STATIN DRUGS AND DIETARY ISOPRENOIDS AS ANTITHROMBOTIC AGENTS  Academic Article
• Sex Differences in the Recognition, Monitoring, and Management of CKD in Health Care: An Observational Cohort Study  Academic Article
• Should Clinicians Deliver Decision Aids? Further Exploration of the Statin Choice Randomized Trial Results  Conference Paper
• Should we give aspirins and statins to the elderly?  Academic Article
• Should we give aspirins and statins to the elderly?  Academic Article
• Simvastatin Lowers Portal Pressure in Patients With Cirrhosis and Portal Hypertension: A Randomized Controlled Trial  Academic Article
• Simvastatin monotherapy as a potential option for statin-associated muscle symptoms: a case report  Academic Article
• State-of-the-Art-Review : Statins Induce Hypothrombotic States?  Academic Article
• Statin Safety in Chinese: A Population-Based Study of Older Adults  Academic Article
• Statin Therapy and Outcomes in Trials of Nintedanib in Idiopathic Pulmonary Fibrosis  Academic Article
• Statin Therapy in Stroke Prevention: A Meta-analysis Involving 121,000 Patients  Academic Article
• Statin Toxicity From Macrolide Antibiotic Coprescription  Academic Article
• Statin Toxicity From Macrolide Antibiotic Coprescription  Academic Article
• Statin Use Associates with a Lower Incidence of Acute Kidney Injury after Major Elective Surgery  Academic Article
• Statin Use and Survival in Patients with Metastatic Castration-resistant Prostate Cancer Treated with Abiraterone Acetate  Academic Article
• Statin Use in Primary Prevention: A Simple Trial-Based Approach Compared With Guideline-Recommended Risk Algorithms for Selection of Eligible Patients  Academic Article
• Statin administration activates system xC⁻ in skeletal muscle: a potential mechanism explaining statin-induced muscle pain  Academic Article
• Statin myopathies: pathophysiologic and clinical perspectives.  Academic Article
• Statin prescription in patients with chronic obstructive pulmonary disease and risk of exacerbations: a retrospective cohort study in the Clinical Practice Research Datalink  Academic Article
• Statin therapy for prevention and treatment of acute and chronic cardiovascular disease: update on recent trials and metaanalyses  Academic Article
• Statin therapy in the treatment of active cancer: A systematic review and meta-analysis of randomized controlled trials  Academic Article
• Statin treatment and accrual of covert cerebral ischaemia on neuroimaging: a systematic review and meta‐analysis of randomized trials  Academic Article
• Statin treatment and cerebral microbleeds: A systematic review and meta-analysis  Academic Article
• Statin use and all-cause mortality in people living with HIV: a systematic review and meta-analysis  Academic Article
• Statin-Associated Rhabdomyolysis: Is There a Dose-Response Relationship?  Academic Article
• Statin-associated Autoimmune Myopathies: A Pathophysiologic Spectrum  Academic Article
• Statin-associated neuromyotoxicity  Academic Article
• Statin-associated neuromyotoxicity.  Academic Article
• Statins Promote Interleukin-1β–Dependent Adipocyte Insulin Resistance Through Lower Prenylation, Not Cholesterol  Academic Article
• Statins activate the NLRP3 inflammasome and impair insulin signaling via p38 and mTOR  Academic Article
• Statins and Intracerebral Hemorrhage  Academic Article
• Statins and Intracerebral Hemorrhage  Academic Article
• Statins and Musculoskeletal Adverse Events  Academic Article
• Statins and Musculoskeletal Adverse Events  Academic Article
• Statins and Thrombin  Academic Article
• Statins and renovascular disease in the elderly: a population-based cohort study  Academic Article
• Statins for acute coronary syndrome  Academic Article
• Statins for acute coronary syndrome  Academic Article
• Statins for high cholesterol … and for low platelets?  Academic Article
• Statins for people with kidney disease  Academic Article
• Statins in patients with sepsis and ARDS: is it over? Yes  Academic Article
• Statins in the prevention of venous thromboembolism: A meta-analysis of observational studies  Academic Article
• Statins: A new pharmacological agent for free flap surgery?  Academic Article
• Statins: pleiotropic, but less than previously thought  Academic Article
• Strength of evidence for perioperative use of statins to reduce cardiovascular risk: systematic review of controlled studies  Academic Article
• Surgical biology for the clinician: vascular effects of immunosuppression.  Academic Article
• Systematic Review on the Risk and Benefit of Different Cholesterol-Lowering Interventions  Academic Article
• Systematic Review: Comparative Effectiveness and Harms of Combination Therapy and Monotherapy for Dyslipidemia  Academic Article
• Targeting Cholesterol Crystal-Induced Inflammation for the Secondary Prevention of Cardiovascular Disease  Academic Article
• Targeting the Unstable Plaque in Acute Coronary Syndromes  Academic Article
• Temporal Patterns of Lipid Testing and Statin Therapy in Acute Coronary Syndrome Patients (from the Canadian GRACE Experience)  Academic Article
• The CHORUS (Cerivastatin in Heart Outcomes in Renal Disease: Understanding Survival) protocol: A double-blind, placebo-controlled trial in patients with ESRD  Conference Paper
• The CHORUS (Cerivastatin in Heart Outcomes in Renal Disease: Understanding Survival) protocol: a double-blind, placebo-controlled trial in patients with esrd.  Academic Article
• The Detection, Evaluation, and Management of Dyslipidemia in Children and Adolescents: A Canadian Cardiovascular Society/Canadian Pediatric Cardiology Association Clinical Practice Update  Academic Article
• The International Polycap Study-3 (TIPS-3): Design, baseline characteristics and challenges in conduct  Academic Article
• The New Dyslipidemia Guidelines: What Is the Debate?  Academic Article
• The cost implication of primary prevention in the HOPE 3 trial  Academic Article
• The cost implications of a polypill for primary prevention in the TIPS-3 trial  Academic Article
• The effect of alternative summary statistics for communicating risk reduction on decisions about taking statins: a randomized trial  Academic Article
• The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials  Academic Article
• The effects of quinapril and atorvastatin on artery structure and function in adult spontaneously hypertensive rats  Academic Article
• The impact of oral hypoglycemics and statins on outcomes in myelodysplastic syndromes  Academic Article
• The impact of statins on physical activity and exercise capacity: an overview of the evidence, mechanisms, and recommendations  Academic Article
• The need to test the theories behind the Polypill: rationale behind the Indian Polycap Study  Academic Article
• The number needed to treat (NNT) can be adjusted for bias when the outcome is measured with error  Academic Article
• The polypill: from concept and evidence to implementation  Academic Article
• There seems to be a higher proportion of patients with apical periodontitis who heal among those who consume statins regularly than among those who do not  Academic Article
• Treatment with atorvastatin ameliorates hepatic very[ndash ]low-density lipoprotein overproduction in an animal model of insulin resistance, the fructose-fed Syrian golden hamster: Evidence that reduced hypertriglyceridemia is accompanied by improved hepatic insulin sensitivity  Academic Article
• Updated evidence on early statin therapy for acute coronary syndromes: Meta-analysis of 18 randomized trials involving over 14,000 patients  Academic Article
• Use of Combination Evidence-Based Medical Therapy Prior to Acute Myocardial Infarction (from the National Registry of Myocardial Infarction-4)  Academic Article
• Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases  Academic Article
• Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey  Academic Article
• Vascular viewpoint  Academic Article
• Who Should Receive HMG CoA Reductase Inhibitors?  Academic Article
• Why do people not take life-saving medications? The case of statins  Academic Article
• [A patient with the homozygote form of familial hypercholesterolemia].  Academic Article